Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 617

1.

New oral anticoagulant and antiplatelet agents for neurosurgeons.

Kimpton G, Dabbous B, Leach P.

Br J Neurosurg. 2015 Jun 3:1-8. [Epub ahead of print]

PMID:
26037940
2.

Effects of anticoagulants on outcome of femoral neck fracture surgery.

Ginsel BL, Taher A, Whitehouse SL, Bell JJ, Pulle CR, Crawford RW.

J Orthop Surg (Hong Kong). 2015 Apr;23(1):29-32.

3.

Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics.

Beitelshees AL, Voora D, Lewis JP.

Pharmgenomics Pers Med. 2015 Feb 9;8:43-61. doi: 10.2147/PGPM.S52900. eCollection 2015. Review.

4.

Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score.

Lip GY, Skjøth F, Rasmussen LH, Larsen TB.

J Am Coll Cardiol. 2015 Apr 14;65(14):1385-94. doi: 10.1016/j.jacc.2015.01.044. Epub 2015 Mar 11.

PMID:
25770314
5.

ACP Journal Club: after initial anticoagulation for a first unprovoked venous thromboembolism, aspirin reduced recurrence.

Dunn A.

Ann Intern Med. 2015 Feb 17;162(4):JC5. doi: 10.7326/ACPJC-2015-162-4-005. No abstract available.

PMID:
25686192
6.

Response to letter regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control".

Chan PH, Hai JJ, Siu CW.

Stroke. 2015 Mar;46(3):e72. doi: 10.1161/STROKEAHA.114.008581. Epub 2015 Feb 3. No abstract available.

PMID:
25649808
7.

Letter by Feng et al regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control".

Feng X, Huan Y, Lv Y.

Stroke. 2015 Mar;46(3):e71. doi: 10.1161/STROKEAHA.114.008578. Epub 2015 Feb 3. No abstract available.

PMID:
25649800
8.

Efficacy and safety of oral anticoagulants versus aspirin for patients with atrial fibrillation: a meta-analysis.

Zhang JT, Chen KP, Zhang S.

Medicine (Baltimore). 2015 Jan;94(4):e409. doi: 10.1097/MD.0000000000000409. Review.

PMID:
25634169
9.

Assessment of risk of late rectal bleeding for patients with prostate cancer started on anticoagulation before or after radiation treatment.

Schreiber D, Chen SC, Rineer J, Worth M, Telivala T, Schwartz D.

Anticancer Res. 2014 Dec;34(12):7367-72.

PMID:
25503174
10.

Antithrombotic and anticoagulant therapy for atrial fibrillation.

Dzeshka MS, Lip GY.

Cardiol Clin. 2014 Nov;32(4):585-99. doi: 10.1016/j.ccl.2014.07.009. Epub 2014 Sep 2. Review.

PMID:
25443239
11.

Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?

Huber K, Bates ER, Valgimigli M, Wallentin L, Kristensen SD, Anderson JL, Lopez Sendon JL, Tubaro M, Granger CB, Bode C, Ohman EM, Steg PG.

Am Heart J. 2014 Nov;168(5):611-21. doi: 10.1016/j.ahj.2014.06.014. Epub 2014 Jun 26. Review.

PMID:
25440788
12.

Management of peri-operative anti-thrombotic therapy.

van Veen JJ, Makris M.

Anaesthesia. 2015 Jan;70 Suppl 1:58-67, e21-3. doi: 10.1111/anae.12900. Review.

PMID:
25440397
13.

Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.

Ho CW, Ho MH, Chan PH, Hai JJ, Cheung E, Yeung CY, Lau KK, Chan KH, Lau CP, Lip GY, Leung GK, Tse HF, Siu CW.

Stroke. 2015 Jan;46(1):23-30. doi: 10.1161/STROKEAHA.114.006476. Epub 2014 Nov 18.

PMID:
25406148
14.

Intensity and quality of warfarin anticoagulation in Chinese patients: setting the record straight.

Eikelboom JW, Hart RG.

Stroke. 2015 Jan;46(1):5-6. doi: 10.1161/STROKEAHA.114.007486. Epub 2014 Nov 18. No abstract available.

PMID:
25406147
15.

Optimising pharmacotherapy for secondary prevention of non-invasively managed acute coronary syndrome.

Thompson PL, Thompson AG, Judkins C.

Med J Aust. 2014 Nov 17;201(10):S100-5.

PMID:
25390495
16.

Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.

Pullicino PM, Qian M, Sacco RL, Freudenberger R, Graham S, Teerlink JR, Mann D, Di Tullio MR, Ponikowski P, Lok DJ, Anker SD, Lip GY, Estol CJ, Levin B, Mohr JP, Thompson JL, Homma S; WARCEF Investigators.

Cerebrovasc Dis. 2014;38(3):176-81. doi: 10.1159/000365502. Epub 2014 Oct 9.

PMID:
25300706
17.

Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.

Thompson PL, Verheugt FW.

Clin Ther. 2014 Sep 1;36(9):1176-81. doi: 10.1016/j.clinthera.2014.08.010.

PMID:
25234549
18.

Anticoagulation management of left ventricular assist devices.

Connors JM.

Am J Hematol. 2015 Feb;90(2):175-8. doi: 10.1002/ajh.23836. Epub 2014 Sep 17. No abstract available.

PMID:
25163820
19.

Atrial fibrillation and coronary artery disease: which antithrombotic treatment strategy?

Lamberts M, Dewilde W, Hansen ML.

Curr Opin Cardiol. 2014 Nov;29(6):595-600. doi: 10.1097/HCO.0000000000000106. Review.

PMID:
25159278
20.

[The clinical analysis of atrial fibrillation of 1 310 in patients in Urumqi of China].

Guo X, Zhang Y, Xu G, Zhou X, Li L, Tang B.

Zhonghua Nei Ke Za Zhi. 2014 May;53(5):371-4. Chinese.

PMID:
25146403
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk